Laidlaw and Company offer wealth management and investment banking to individuals in the United Kingdom and the United States. Raising capital by equity placement with institutions; acquisition financing; planning of national exchange listing; debt placement; United States trading markets are some of the services the company offer on investment banking. The firm also provides fairness opinions, and advice on acquisitions.
The Laidlaw and Company owe its success to a well able team of experts. Mr. Mathew D. Eiter is the Chief Executive Officer. Mr. James P.Ahern holds the position of the Managing Partner and Head of Capital Markets. Mr. Hugh Regan offers his expertise as the Executive Director of Investment Banking and Head of Laidlaw Private Equity. The Senior Managing Director is Mr. Craig Brown, and Mr. Hugh J. Marasa holds the position o the Senior Managing Director.
Laidlaw offer personalized skillful and advice on execution to both private and public institutions. To individuals with high net worth, the services are also available. For more information on this read http://laidlawltd.com/.
The firm receives complaints as well as testimonies from their clients on the different services they render. On their website, the WSO is where clients pose their various concerns and questions concerning the Laidlaw and Company. On the investment banking WSO can be used for different functions: Financial Modeling Training, IB Interview Prep Pack, and Resume Help from Actual IB Pros among others.one can follow the firm on Facebook, Twitter, google+, 800 notes and LinkedIn.
Laidlaw and company, LTD has had several key developments. Among them include; Relmanda Therapeutics, Inc. Files Amended Complaint Against Laidlaw and Company: the company made expansions in the London office and added two team members who were to build on the current clients and infrastructure in the wealth management division, the company did some Executive changes. More info posted on the PR Newswire website.
Read more on the developments from http://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=183312.